{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:44:36Z","timestamp":1794440676267,"version":"4.9.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.beem.2024.101966","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T11:25:36Z","timestamp":1735298736000},"page":"101966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Parathyroid carcinoma: New insights"],"prefix":"10.1016","volume":"39","author":[{"given":"Abhishek","family":"Viswanath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftychia E.","family":"Drakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fannie","family":"Lajeunesse-Trempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios K.","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061426","article-title":"Parathyroid carcinoma: incidence, survival analysis, and management: a study from the SEER database and insights into future therapeutic perspectives","volume":"14","author":"Ullah","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2024.101966_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijscr.2017.11.030","article-title":"Parathyroid carcinoma: from a case report to a review of the literature","volume":"42","author":"Fernandes","year":"2018","journal-title":"Int J Surg Case Rep"},{"issue":"4","key":"10.1016\/j.beem.2024.101966_bib3","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0287","article-title":"Diagnosis and management of parathyroid carcinoma: a state-of-the-art review","volume":"30","author":"Roser","year":"2023","journal-title":"Endocr-Relat Cancer"},{"key":"10.1016\/j.beem.2024.101966_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1761030","article-title":"Clinical features, treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature","volume":"2019","author":"Torresan","year":"2019","journal-title":"Int J Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2024.101966_bib5","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/clinem\/dgad368","article-title":"Phenotypic profiling and molecular mechanisms in hyperparathyroidism-jaw tumor syndrome","volume":"108","author":"Tora","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101966_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.557050","article-title":"Prevalence of parathyroid carcinoma and atypical parathyroid neoplasms in 153 patients with multiple endocrine neoplasia type 1: case series and literature review","volume":"11","author":"Song","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2024.101966_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","article-title":"Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge. The MD Anderson case series and review of the literature","volume":"31","author":"Christakis","year":"2016","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib8","first-page":"289","article-title":"Parathyroid disorders","volume":"105","author":"Sell","year":"2022","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.beem.2024.101966_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112329","article-title":"Advances in the management of parathyroid carcinoma","volume":"592","author":"Kubal","year":"2024","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13193-021-01343-3","article-title":"Parathyroid Carcinoma: a Review","volume":"13","author":"Sawhney","year":"2022","journal-title":"Indian J Surg Oncol"},{"issue":"4","key":"10.1016\/j.beem.2024.101966_bib11","first-page":"295","article-title":"Parathyroid carcinoma. A single Institution experience and a review of the international literature","volume":"89","author":"Quaglino","year":"2018","journal-title":"Ann Ital Chir"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40463-016-0178-7","article-title":"The dangers of parathyroid biopsy","volume":"46","author":"Kim","year":"2017","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59030448","article-title":"Parathyroid cancer-a rare finding during parathyroidectomy in high volume surgery centre","volume":"59","author":"Radu","year":"2023","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1245\/s10434-020-08825-8","article-title":"The use and benefit of adjuvant radiotherapy in parathyroid carcinoma: a national cancer database analysis","volume":"28","author":"Limberg","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.beem.2024.101966_bib16","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1245\/s10434-015-4672-3","article-title":"Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the national cancer data base (NCDB)","volume":"22","author":"Asare","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/EP:16:1:049","article-title":"Proposal for the histological classification of parathyroid carcinoma","volume":"16","author":"Kameyama","year":"2005","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.beem.2024.101966_bib19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1507\/endocrj.50.527","article-title":"Trial to predict malignancy of affected parathyroid glands in primary hyperparathyroidism","volume":"50","author":"Chen","year":"2003","journal-title":"Endocr J"},{"issue":"8","key":"10.1016\/j.beem.2024.101966_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3346\/jkms.2012.27.8.890","article-title":"Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism","volume":"27","author":"Bae","year":"2012","journal-title":"J Korean Med Sci"},{"issue":"7","key":"10.1016\/j.beem.2024.101966_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/ASO.2005.06.005","article-title":"Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature","volume":"12","author":"Robert","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib22","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1210\/jc.2013-3730","article-title":"The third\/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform","volume":"99","author":"Cavalier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101966_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0169","article-title":"Human chorionic gonadotropin measurements in parathyroid carcinoma","volume":"159","author":"Rubin","year":"2008","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s12020-024-03831-2","article-title":"Detection and identification of circulating tumor cells in parathyroid tumors and correlation analysis with clinicopathological features","volume":"85","author":"Wang","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.surg.2023.07.043","article-title":"Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?","volume":"175","author":"Szabo Yamashita","year":"2024","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.beem.2024.101966_bib26","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1210\/jc.2011-1571","article-title":"Parathyroid carcinoma: a 43-year outcome and survival analysis","volume":"96","author":"Harari","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101966_bib27","unstructured":"Lazzaro A., Zhao G., Kulke M. Diagnosis and Management of Parathyroid Carcinoma. Clinical Pharmacology & Therapeutics.n\/a(n\/a)."},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1272\/jnms.JNMS.2023_90-604","article-title":"Usefulness of ultrasonographic detective flow imaging for detecting parathyroid tumors: a report of two cases","volume":"90","author":"Matsui","year":"2023","journal-title":"J Nippon Med Sch"},{"issue":"14","key":"10.1016\/j.beem.2024.101966_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16142593","article-title":"Imaging recommendations for diagnosis and management of primary parathyroid pathologies: a comprehensive review","volume":"16","author":"Chakrabarty","year":"2024","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.beem.2024.101966_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14141548","article-title":"Dual-tracer positron emission tomography\/computed tomography with [(18)F]FDG and [(18)F]fluorocholine in a patient with metastatic parathyroid carcinoma","volume":"14","author":"Iacovitti","year":"2024","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/nu15010188","article-title":"Usefulness of PET\/CT with carbon-11-labeled methionine in the diagnosis of tertiary hyperparathyroidism","volume":"15","author":"Ko\u0142odziej","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.beem.2024.101966_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejrad.2017.07.026","article-title":"The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma","volume":"95","author":"Christakis","year":"2017","journal-title":"Eur J Radio"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3174\/ajnr.A2805","article-title":"Diagnostic accuracy of 4D-CT for parathyroid adenomas and hyperplasia","volume":"33","author":"Chazen","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"10.1016\/j.beem.2024.101966_bib34","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00268-012-1707-9","article-title":"Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism","volume":"36","author":"Karakas","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2024.101966_bib35","doi-asserted-by":"crossref","DOI":"10.1507\/endocrj.EJ23-0149","article-title":"Parathyroid carcinoma: impact of preoperative diagnosis on the choice of surgical procedure","volume":"70","author":"Kawai","year":"2023","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib36","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s12020-024-03687-6","article-title":"The significance of an immunohistochemical marker-based panel in assisting the diagnosis of parathyroid carcinoma","volume":"84","author":"Hu","year":"2024","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/ijem.ijem_208_22","article-title":"Clinicopathological profile of primary hyperparathyroidism with special reference to Ki-67 labelling index","volume":"27","author":"Thanveer","year":"2023","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2024.101966_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1507\/endocrj.EJ18-0387","article-title":"Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity","volume":"66","author":"Ciuffi","year":"2019","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.beem.2024.101966_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/clinem\/dgad455","article-title":"Approach to the patient with parathyroid carcinoma","volume":"109","author":"Cetani","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2024.101966_bib41","article-title":"Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: a case report and review of the literature","volume":"11","author":"Garrigues","year":"2023","journal-title":"Mol Genet Genom Med"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12020-023-03376-w","article-title":"Parathyroid carcinoma: molecular therapeutic targets","volume":"81","author":"Marini","year":"2023","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib43","article-title":"PIK3CA mutational analysis of parathyroid adenomas","volume":"4","author":"Riccardi","year":"2020","journal-title":"JBMR"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic profiling reveals mutational landscape in parathyroid carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic profiling of parathyroid carcinoma reveals genomic alterations suggesting benefit from therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.beem.2024.101966_bib46","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/js.2019-00175","article-title":"MGMT promoter methylation and parathyroid carcinoma","volume":"3","author":"Storvall","year":"2019","journal-title":"J Endocr Soc"},{"issue":"7","key":"10.1016\/j.beem.2024.101966_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102065","article-title":"A novel LncRNA PTH-AS upregulates interferon-related DNA damage resistance signature genes and promotes metastasis in human breast cancer xenografts","volume":"298","author":"Akimoto","year":"2022","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.beem.2024.101966_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910465","article-title":"Are non-coding RNAs useful biomarkers in parathyroid tumorigenesis?","volume":"22","author":"Aurilia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2024.101966_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.869006","article-title":"The long non-coding BC200 is a novel circulating biomarker of parathyroid carcinoma","volume":"13","author":"Morotti","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.beem.2024.101966_bib50","first-page":"1959","article-title":"A practical approach to hypercalcemia","volume":"67","author":"Carroll","year":"2003","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.380","article-title":"Management of severe hypercalcaemia secondary to primary hyperparathyroidism: the efficacy of saline hydration, furosemide, and zoledronic acid","volume":"5","author":"Oueslati","year":"2022","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.beem.2024.101966_bib52","series-title":"Calcitonin. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024","author":"McLaughlin","year":"2024"},{"key":"10.1016\/j.beem.2024.101966_bib53","series-title":"Bisphosphonate. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024","author":"Ganesan","year":"2024"},{"key":"10.1016\/j.beem.2024.101966_bib54","article-title":"Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials","volume":"13","author":"Lu","year":"2023","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.beem.2024.101966_bib55","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pr"},{"issue":"15","key":"10.1016\/j.beem.2024.101966_bib56","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp2113128","article-title":"Cancer-associated hypercalcemia","volume":"386","author":"Guise","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beem.2024.101966_bib57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14656566.2017.1303482","article-title":"Etelcalcetide for the treatment of secondary hyperparathyroidism","volume":"18","author":"Hamano","year":"2017","journal-title":"Expert Opin Pharm"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100475","article-title":"Etelcalcetide versus cinacalcet in hemodialysis patients in the United States: a facility calcimimetic approach to assess real-world effectiveness","volume":"4","author":"Karaboyas","year":"2022","journal-title":"Kidney Med"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12020-019-02136-z","article-title":"Long-term remission of disseminated parathyroid cancer following immunotherapy","volume":"67","author":"Sarquis","year":"2020","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib60","doi-asserted-by":"crossref","first-page":"A1008","DOI":"10.1210\/jendso\/bvab048.2062","article-title":"Use of temozolomide in parathyroid carcinoma with negative Mgmt promoter methylation","volume":"5","author":"Reddy","year":"2021","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13045-019-0718-5","article-title":"Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy","volume":"12","author":"Qin","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10.1016\/j.beem.2024.101966_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004635","article-title":"The dual function of KDM5C in both gene transcriptional activation and repression promotes breast cancer cell growth and tumorigenesis","volume":"8","author":"Shen","year":"2021","journal-title":"Adv Sci"},{"issue":"2","key":"10.1016\/j.beem.2024.101966_bib63","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2024.101966_bib65","doi-asserted-by":"crossref","first-page":"S1292","DOI":"10.1016\/j.annonc.2023.10.047","article-title":"LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)","volume":"34","author":"Chan","year":"2023","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.beem.2024.101966_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/1878-0261.13398","article-title":"Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling","volume":"17","author":"Teleanu","year":"2023","journal-title":"Mol Oncol"},{"issue":"22","key":"10.1016\/j.beem.2024.101966_bib67","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.2169\/internalmedicine.9261-21","article-title":"Successful control of hypercalcemia with sorafenib, evocalcet, and denosumab combination therapy for recurrent parathyroid carcinoma","volume":"61","author":"Makino","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.beem.2024.101966_bib68","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fendo.2019.00731","article-title":"The Clinicopathological spectrum of parathyroid carcinoma","volume":"10","author":"Akirov","year":"2019","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2024.101966_bib69","article-title":"Sporadic parathyroid carcinoma treated with lenvatinib, exhibiting a novel somatic MEN1 mutation","volume":"2","author":"Ito","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"17","key":"10.1016\/j.beem.2024.101966_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36656","article-title":"Efficacy of surufatinib in the treatment of advanced parathyroid carcinoma: a case report","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.beem.2024.101966_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/03000605241259669","article-title":"Long-term survival in a patient with metastatic parathyroid carcinoma harboring an EGFR sensitizing mutation: a case report","volume":"52","author":"Ying","year":"2024","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib72","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(15)70136-1","article-title":"Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study","volume":"16","author":"Phan","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"8","key":"10.1016\/j.beem.2024.101966_bib74","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.beem.2024.101966_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.643328","article-title":"Case report: abdominal lymph node metastases of parathyroid carcinoma: diagnostic workup, molecular diagnosis, and clinical management","volume":"12","author":"Lenschow","year":"2021","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2024.101966_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235293","article-title":"Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab","volume":"13","author":"Park","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.beem.2024.101966_bib77","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcu.23181","article-title":"Radiofrequency ablation of parathyroid adenomas causing primary hyperparathyroidism: a report of 27 patients","volume":"50","author":"Ebrahiminik","year":"2022","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.beem.2024.101966_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.982972","article-title":"Diagnosis and treatment of liver metastases of parathyroid carcinoma","volume":"13","author":"Su","year":"2022","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2024.101966_bib79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4066\/AMJ.2014.2084","article-title":"Metastatic parathyroid carcinoma treated with radiofrequency ablation: a novel therapeutic modality","volume":"7","author":"DasGupta","year":"2014","journal-title":"Austral Med J"},{"issue":"12","key":"10.1016\/j.beem.2024.101966_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123049","article-title":"Somatostatin analogues in the treatment of neuroendocrine tumors: past, present and future","volume":"20","author":"Stueven","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.beem.2024.101966_bib81","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-2007-979858","article-title":"Somatostatin and octreotide interfere with calcium signalling in pancreatic beta-cells but not in normal and pathological parathyroid cells","volume":"28","author":"Ridefelt","year":"1996","journal-title":"Horm Metab Res"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061267","article-title":"Indications of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic and pulmonary neuroendocrine tumors: an updated review","volume":"10","author":"Camus","year":"2021","journal-title":"J Clin Med"},{"issue":"10446","key":"10.1016\/j.beem.2024.101966_bib83","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","volume":"403","author":"Singh","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib84","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12020-015-0702-y","article-title":"Role of (68)Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1)","volume":"52","author":"Lastoria","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2024.101966_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2023.103843","article-title":"Parathyroid carcinoma: current management and outcomes \u2013 a systematic review","volume":"44","author":"McInerney","year":"2023","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib86","first-page":"56","article-title":"Parathyroid carcinoma \u2014 a study of 29 cases","volume":"73","author":"Kowalski","year":"2022","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.beem.2024.101966_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1310290","article-title":"Giant functional parathyroid carcinoma: a case report and literature review","volume":"13","author":"Wu","year":"2024","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.beem.2024.101966_bib88","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2169\/internalmedicine.33.697","article-title":"Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma","volume":"33","author":"Koyano","year":"1994","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.beem.2024.101966_bib89","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/01455613211016703","article-title":"Oligometastatic parathyroid carcinoma presenting as neck pain: a case report","volume":"102","author":"Yu","year":"2023","journal-title":"Ear Nose Throat J"},{"issue":"4","key":"10.1016\/j.beem.2024.101966_bib90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4174\/astr.2024.106.4.203","article-title":"Outcomes of bilateral axillo-breast approach robotic parathyroidectomy versus open parathyroidectomy for primary hyperparathyroidism: a single-institution retrospective study","volume":"106","author":"Choi","year":"2024","journal-title":"Ann Surg Treat Res"},{"issue":"9","key":"10.1016\/j.beem.2024.101966_bib91","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/02692163231194838","article-title":"Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomised controlled trials","volume":"37","author":"Liu","year":"2023","journal-title":"Palliat Med"},{"issue":"6","key":"10.1016\/j.beem.2024.101966_bib92","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.21037\/gs-21-50","article-title":"Bilateral axillo-breast approach robotic thyroidectomy: review of a single surgeon's consecutive 317 cases","volume":"10","author":"You","year":"2021","journal-title":"Gland Surg"},{"issue":"3","key":"10.1016\/j.beem.2024.101966_bib93","doi-asserted-by":"crossref","first-page":"953","DOI":"10.21037\/gs-20-761","article-title":"Robotic-assisted parathyroidectomy via transaxillary approach: feasibility and learning curves","volume":"10","author":"Kandil","year":"2021","journal-title":"Gland Surg"},{"issue":"2","key":"10.1016\/j.beem.2024.101966_bib94","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s12070-023-03499-6","article-title":"Parathyroid carcinoma: lessons from a rare malignancy of head and neck-a case series","volume":"75","author":"Mani","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.beem.2024.101966_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1278178","article-title":"Management and surgical treatment of parathyroid carcinoma: a 6-year experience of a single centre of endocrine surgery unit","volume":"14","author":"Laforgia","year":"2023","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2024.101966_bib96","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad067","article-title":"Time to recurrence as a prognostic factor in parathyroid carcinoma","volume":"7","author":"Magnabosco","year":"2023","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.beem.2024.101966_bib97","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12902-023-01344-z","article-title":"Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience","volume":"23","author":"Ionova","year":"2023","journal-title":"BMC Endocr Disord"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T05:32:52Z","timestamp":1741843972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24001428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521690X24001428"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101966","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid carcinoma: New insights","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101966"}}